This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Norén, T. Articles by Burman, L. G. Search for Related Content PubMed PubMed Citation Articles by Norén, T. Articles by Burman, L. G.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2004, p. 3635-3643, Vol. 42, No. 8
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.8.3635-3643.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Molecular Epidemiology of Hospital-Associated and Community-Acquired Clostridium difficile Infection in a Swedish County

Department of Infectious Diseases,¹ Department of Clinical Microbiology, Örebro University Hospital, Örebro,³ Swedish Institute for Infectious Disease Control, Solna, Sweden²

Received 21 December 2003/ Returned for modification 13 February 2004/ Accepted 8 April 2004

All episodes of Clostridium difficile associated diarrhea (CDAD) diagnosed in a defined population of 274,000 including one tertiary and two primary hospitals and their catchment areas were studied during 12 months. The annual CDAD incidence in the county was 97 primary episodes per 100,000, and 78% of all episodes were classified as hospital associated with a mean incidence of 5.3 (range, 1.4 to 6.5) primary episodes per 1,000 admissions. The incidence among hospitalized individuals was 1,300-fold higher than that in the community (33,700 versus 25 primary episodes per 100,000 persons per year), reflecting a 37-fold difference in antibiotic consumption (477 versus 13 defined daily doses [DDD]/1,000 persons/day) and other risk factors. Three tertiary hospital wards with the highest incidence (13 to 36 per 1,000) had CDAD patients of high age (median age of 80 years versus 70 years for other wards, P < 0.001), long hospital stay (up to 25 days versus 4 days), or a high antibiotic consumption rate (up to 2,427 versus 421 DDD/1,000 bed days). PCR ribotyping of C. difficile isolates available from 330 of 372 CDAD episodes indicated nosocomial acquisition of the strain in 17 to 27% of hospital-associated cases, depending on the time interval between index and secondary cases allowed (2 months or up to 12 months), and only 10% of recurrences were due to a new strain of C. difficile (apparent reinfection). In other words, most primary and recurring episodes were apparently caused by the patient's endogenous strain rather than by one of hospital origin. Typing also indicated that a majority of C. difficile strains belonged to international serotypes, and the distribution of types was similar within and outside hospitals and in primary and relapsing CDAD. However, type SE17 was an exception, comprising 22% of hospital isolates compared to 6% of community isolates (P = 0.008) and causing many minor clusters and a silent nosocomial outbreak including 36 to 44% of the CDAD episodes in the three high-incidence wards.

This article has been cited by other articles:

• Wilcox, M. H., Mooney, L., Bendall, R., Settle, C. D., Fawley, W. N. (2008). A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 62: 388-396 [Abstract] [Full Text]  
• Zumbado-Salas, R., del Mar Gamboa-Coronado, M., Rodriguez-Cavallini, E., Chaves-Olarte, E. (2008). Clostridium difficile in Adult Patients with Nosocomial Diarrhea in a Costa Rican Hospital. Am J Trop Med Hyg 79: 164-165 [Abstract] [Full Text]  
• Akerlund, T., Persson, I., Unemo, M., Noren, T., Svenungsson, B., Wullt, M., Burman, L. G. (2008). Increased Sporulation Rate of Epidemic Clostridium difficile Type 027/NAP1. J. Clin. Microbiol. 46: 1530-1533 [Abstract] [Full Text]  
• Blossom, D. B., Lewis, F. M.T., McDonald, L. C. (2008). The Changing Spectrum of Clostridium Difficile Associated Disease: Implications for Dentistry. Journal of the American Dental Association 139: 42-47 [Abstract] [Full Text]  
• Noren, T., Akerlund, T., Wullt, M., Burman, L. G., Unemo, M. (2007). Mutations in fusA Associated with Posttherapy Fusidic Acid Resistance in Clostridium difficile. Antimicrob. Agents Chemother. 51: 1840-1843 [Abstract] [Full Text]  
• Noren, T., Wullt, M., Akerlund, T., Back, E., Odenholt, I., Burman, L. G. (2006). Frequent Emergence of Resistance in Clostridium difficile during Treatment of C. difficile-Associated Diarrhea with Fusidic Acid.. Antimicrob. Agents Chemother. 50: 3028-3032 [Abstract] [Full Text]  
• Leffler, D., Cloud, J. W., Kelly, C. P. (2006). Gastric acid-suppressive agents and risk of Clostridium difficile-associated disease.. JAMA 295: 2599-2600 [Full Text]  
• Terhes, G., Brazier, J. S., Urban, E., Soki, J., Nagy, E. (2006). Distribution of Clostridium difficile PCR ribotypes in regions of Hungary.. J Med Microbiol 55: 279-282 [Abstract] [Full Text]  
• Akerlund, T., Svenungsson, B., Lagergren, A., Burman, L. G. (2006). Correlation of Disease Severity with Fecal Toxin Levels in Patients with Clostridium difficile-Associated Diarrhea and Distribution of PCR Ribotypes and Toxin Yields In Vitro of Corresponding Isolates. J. Clin. Microbiol. 44: 353-358 [Abstract] [Full Text]  
• Dial, S., Delaney, J. A. C., Barkun, A. N., Suissa, S. (2005). Use of Gastric Acid-Suppressive Agents and the Risk of Community-Acquired Clostridium difficile-Associated Disease. JAMA 294: 2989-2995 [Abstract] [Full Text]